Correlation of response with survival endpoints in patients with newly diagnosed and recurrent glioblastoma (GBM) treated on prospective North Central Cancer Treatment Group (NCCTG) clinical trials
- Citation:
- J Clin Oncol vol 26 (15s, pt I) 95s abstr 2024
- Meeting Instance:
- ASCO 2008
- Year:
- 2008
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 89
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- K. A. Jaeckle W. Wu M. Kosel P. J. Flynn J. C. Buckner
- Networks:
- Study
- NCCTG-N047D
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- N/A
- Keywords: